(MSDL) Morgan Stanley Direct - Ratings and Ratios

Exchange: NYSE • Country: USA • Currency: USD • Type: Common Stock • ISIN: US61774A1034

MSDL: Direct Lending, Corporate Loans, Asset-Based Financing, Capital Financing

Ticker Symbol: MSDL | Exchange: NYSE | Type: Common Stock | Country Origin: USA | GICS Sub Industry: Diversified Financial Services. Morgan Stanley Direct Lending Fund (MSDL) operates as a business development company (BDC) primarily engaged in direct lending to middle-market companies. It focuses on senior secured loans, including first-lien and second-lien debt, as well as other structured credit investments. The fund aims to generate consistent income and capital appreciation through a diversified portfolio of credit investments.

Technical Analysis: Average Volume 20d: 603,843 shares | Last Price: $20.67 | SMA 20: $20.39 | SMA 50: $20.67 | SMA 200: $20.14 | ATR: 0.29. MSDL is trading above its SMA 20 and SMA 200, indicating short-term and long-term bullish momentum. The stock is priced at parity with its SMA 50, suggesting near-term stability. The ATR of 0.29 reflects low volatility, with average price fluctuations of less than 1.4% over the past 20 days.

Fundamental Analysis: Market Cap: $1.85B | P/E: 8.48 | Forward P/E: 9.60 | P/B: 0.99 | P/S: 7.23 | RoE: 11.70%. MSDL is undervalued relative to its forward earnings, with a P/E ratio of 8.48 compared to a forward P/E of 9.60. The P/B ratio of 0.99 indicates the stock is trading near book value, suggesting moderate undervaluation. The price-to-sales ratio of 7.23 is elevated, reflecting a premium for its revenue streams. The return on equity of 11.70% highlights efficient profitability relative to shareholder equity.

3-Month Forecast: Based on and , MSDL is expected to trade in a narrow range near $20.50, supported by its SMA 50 and SMA 200. The low ATR of 0.29 suggests minimal downside risk, with potential upside driven by earnings surprises or positive macroeconomic trends. Fundamentally, the stocks attractive P/E ratio and stable RoE position it for modest capital appreciation, with a target range of $20.75 to $21.25 over the next quarter.

Additional Sources for MSDL Stock

MSDL Stock Overview

Market Cap in USD 1,652m
GiC Sub-Industry Diversified Financial Services
IPO / Inception 2024-01-24

MSDL Stock Ratings

Growth Rating 8.57
Fundamental -
Dividend Rating 44.4
Rel. Strength -11.7
Analysts 3/5
Fair Price Momentum 17.35 USD
Fair Price DCF -

MSDL Dividends

Dividend Yield 12m 11.30%
Yield on Cost 5y 12.11%
Annual Growth 5y -52.33%
Payout Consistency 100.0%

MSDL Growth Ratios

Growth Correlation 3m -72.9%
Growth Correlation 12m -2.8%
Growth Correlation 5y 34%
CAGR 5y 4.10%
CAGR/Max DD 5y 0.23
Sharpe Ratio 12m -0.63
Alpha -4.78
Beta 0.553
Volatility 38.98%
Current Volume 325.4k
Average Volume 20d 565.4k
What is the price of MSDL stocks?
As of April 22, 2025, the stock is trading at USD 19.10 with a total of 325,447 shares traded.
Over the past week, the price has changed by -0.10%, over one month by -5.58%, over three months by -9.42% and over the past year by +0.16%.
Is Morgan Stanley Direct a good stock to buy?
Neither. Based on ValueRay Analyses, Morgan Stanley Direct is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 8.57 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MSDL as of April 2025 is 17.35. This means that MSDL is currently overvalued and has a potential downside of -9.16%.
Is MSDL a buy, sell or hold?
Morgan Stanley Direct has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold MSDL.
  • Strong Buy: 0
  • Buy: 0
  • Hold: 5
  • Sell: 0
  • Strong Sell: 0
What are the forecast for MSDL stock price target?
According to ValueRays Forecast Model, MSDL Morgan Stanley Direct will be worth about 19 in April 2026. The stock is currently trading at 19.10. This means that the stock has a potential downside of -0.68%.
Issuer Forecast Upside
Wallstreet Target Price 20.9 9.4%
Analysts Target Price 21.2 11%
ValueRay Target Price 19 -0.7%